Novavax Aktie
WKN DE: A2PKMZ / ISIN: US6700024010
| 10.05.2024 08:33:15 | 
Novavax Inc. Q1 Loss Decreases, Beats Estimates
(RTTNews) - Novavax Inc. (NVAX) released Loss for first quarter that decreased from last year and beat the Street estimates.
The company's bottom line came in at -$147.550 million, or -$1.05 per share. This compares with -$293.905 million, or -$3.41 per share, in last year's first quarter.
Analysts on average had expected the company to earn -$1.06 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 15.9% to $93.855 million from $80.951 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$147.550 Mln. vs. -$293.905 Mln. last year. -EPS (Q1): -$1.05 vs. -$3.41 last year. -Revenue (Q1): $93.855 Mln vs. $80.951 Mln last year.
 Der finanzen.at Ratgeber für Aktien!
						
						
						
							
								Der finanzen.at Ratgeber für Aktien!
							
							Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
| 05.08.25 | Ausblick: Novavax zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | 
Analysen zu Novavax Inc.mehr Analysen
Aktien in diesem Artikel
| Novavax Inc. | 7,31 | -0,10% |  | 
 
									 
									 
								